A prospective study of DT56a (Femarelle®) for the treatment of menopause symptoms

Objective : The objective of this study was to analyze the efficacy of DT56a in the reduction of menopause symptoms in Spanish women who participated in the Post Marketing Menopausal Symptoms International Survey (POMMSIS)

climacteric 2015;18(6):813-6. doi: 10.3109/13697137.2015.1065247. Epub 2015 Oct 10.